Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 31% ± 15% | |
endothelial cell of vascular tree | 6 studies | 24% ± 13% | |
vein endothelial cell | 5 studies | 21% ± 7% | |
pericyte | 5 studies | 49% ± 21% | |
smooth muscle cell | 4 studies | 30% ± 11% | |
squamous epithelial cell | 3 studies | 35% ± 24% | |
podocyte | 3 studies | 48% ± 10% | |
connective tissue cell | 3 studies | 37% ± 4% | |
basal cell | 3 studies | 38% ± 16% | |
fibroblast | 3 studies | 67% ± 27% | |
endothelial cell of artery | 3 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of FOXC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 2453.78 | 89 / 89 | 89% | 28.86 | 803 / 901 |
prostate | 95% | 1746.38 | 232 / 245 | 91% | 12.77 | 458 / 502 |
esophagus | 77% | 866.15 | 1108 / 1445 | 97% | 31.21 | 177 / 183 |
thymus | 96% | 1162.06 | 625 / 653 | 77% | 24.73 | 468 / 605 |
breast | 98% | 1834.95 | 449 / 459 | 66% | 24.11 | 742 / 1118 |
skin | 89% | 1613.62 | 1609 / 1809 | 65% | 9.48 | 307 / 472 |
bladder | 71% | 646.19 | 15 / 21 | 78% | 18.87 | 391 / 504 |
uterus | 59% | 687.92 | 101 / 170 | 88% | 22.96 | 402 / 459 |
ovary | 59% | 744.02 | 106 / 180 | 77% | 24.13 | 333 / 430 |
lung | 47% | 476.33 | 270 / 578 | 79% | 15.90 | 912 / 1155 |
brain | 42% | 341.65 | 1097 / 2642 | 81% | 8.12 | 568 / 705 |
adrenal gland | 58% | 532.36 | 150 / 258 | 50% | 4.98 | 114 / 230 |
pancreas | 12% | 71.71 | 38 / 328 | 94% | 19.54 | 167 / 178 |
blood vessel | 100% | 13527.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 96% | 1949.06 | 1158 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 15.91 | 39 / 45 |
stomach | 15% | 126.92 | 54 / 359 | 66% | 16.14 | 188 / 286 |
intestine | 18% | 151.58 | 174 / 966 | 52% | 9.17 | 274 / 527 |
heart | 62% | 1081.03 | 534 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 7.60 | 15 / 29 |
liver | 0% | 2.81 | 1 / 226 | 25% | 3.47 | 103 / 406 |
eye | 0% | 0 | 0 / 0 | 23% | 1.36 | 18 / 80 |
muscle | 11% | 91.96 | 88 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 12.63 | 15 / 929 | 0% | 0 | 0 / 0 |
spleen | 1% | 5.29 | 2 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0046620 | Biological process | regulation of organ growth |
GO_0048844 | Biological process | artery morphogenesis |
GO_0001525 | Biological process | angiogenesis |
GO_0001657 | Biological process | ureteric bud development |
GO_0072010 | Biological process | glomerular epithelium development |
GO_0001974 | Biological process | blood vessel remodeling |
GO_1904798 | Biological process | positive regulation of core promoter binding |
GO_0008283 | Biological process | cell population proliferation |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0001701 | Biological process | in utero embryonic development |
GO_0048341 | Biological process | paraxial mesoderm formation |
GO_0007507 | Biological process | heart development |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001541 | Biological process | ovarian follicle development |
GO_0032808 | Biological process | lacrimal gland development |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0001822 | Biological process | kidney development |
GO_0001958 | Biological process | endochondral ossification |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0097746 | Biological process | blood vessel diameter maintenance |
GO_0038084 | Biological process | vascular endothelial growth factor signaling pathway |
GO_0001654 | Biological process | eye development |
GO_0014032 | Biological process | neural crest cell development |
GO_0055010 | Biological process | ventricular cardiac muscle tissue morphogenesis |
GO_0003275 | Biological process | apoptotic process involved in outflow tract morphogenesis |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_1901491 | Biological process | negative regulation of lymphangiogenesis |
GO_0014031 | Biological process | mesenchymal cell development |
GO_0060038 | Biological process | cardiac muscle cell proliferation |
GO_0030203 | Biological process | glycosaminoglycan metabolic process |
GO_1901534 | Biological process | positive regulation of hematopoietic progenitor cell differentiation |
GO_1902038 | Biological process | positive regulation of hematopoietic stem cell differentiation |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0036438 | Biological process | maintenance of lens transparency |
GO_0030154 | Biological process | cell differentiation |
GO_0035050 | Biological process | embryonic heart tube development |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0001756 | Biological process | somitogenesis |
GO_0043388 | Biological process | positive regulation of DNA binding |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0021549 | Biological process | cerebellum development |
GO_1990869 | Biological process | cellular response to chemokine |
GO_0048010 | Biological process | vascular endothelial growth factor receptor signaling pathway |
GO_0043010 | Biological process | camera-type eye development |
GO_0030199 | Biological process | collagen fibril organization |
GO_0045930 | Biological process | negative regulation of mitotic cell cycle |
GO_0001945 | Biological process | lymph vessel development |
GO_1902257 | Biological process | negative regulation of apoptotic process involved in outflow tract morphogenesis |
GO_0008354 | Biological process | germ cell migration |
GO_0045618 | Biological process | positive regulation of keratinocyte differentiation |
GO_0016477 | Biological process | cell migration |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000792 | Cellular component | heterochromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0008301 | Molecular function | DNA binding, bending |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FOXC1 |
Protein name | Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3) Forkhead box C1 FOXC1 protein |
Synonyms | FKHL7 hCG_21926 FREAC3 |
Description | FUNCTION: DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development . Acts either as a transcriptional activator or repressor . Binds to the consensus binding site 5'-[G/C][A/T]AAA[T/C]AA[A/C]-3' in promoter of target genes . Upon DNA-binding, promotes DNA bending . Acts as a transcriptional coactivator . Stimulates Indian hedgehog (Ihh)-induced target gene expression mediated by the transcription factor GLI2, and hence regulates endochondral ossification (By similarity). Acts also as a transcriptional coregulator by increasing DNA-binding capacity of GLI2 in breast cancer cells . Regulates FOXO1 through binding to a conserved element, 5'-GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye . Cooperates with transcription factor FOXC2 in regulating expression of genes that maintain podocyte integrity (By similarity). Promotes cell growth inhibition by stopping the cell cycle in the G1 phase through TGFB1-mediated signals . Involved in epithelial-mesenchymal transition (EMT) induction by increasing cell proliferation, migration and invasion . Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). Plays a role in the gene regulatory network essential for epidermal keratinocyte terminal differentiation . Essential developmental transcriptional factor required for mesoderm-derived tissues, such as the somites, skin, bone and cartilage. Positively regulates CXCL12 and stem cell factor expression in bone marrow mesenchymal progenitor cells, and hence plays a role in the development and maintenance of mesenchymal niches for haematopoietic stem and progenitor cells (HSPC). Plays a role in corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development in a VEGF-dependent manner. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). May function as a tumor suppressor . . |
Accessions | ENST00000645831.2 A3KPE3 Q12948 C6KMR8 W6CJ52 |